All Stocks
pharma

MRK — Merck & Co. Inc.

Conviction25
Congress 90d0
Insider 90d0
Markets0
Lobbying7
Contracts0
CountryUS

MRK

Merck & Co. Inc.

pharma
25thin · 1 src1 source agree
📋 Lobbying

Congressional trades

No congressional trades in the last 90 days.

Prediction markets

No prediction markets reference this stock.

Lobbying filings

Last 2 years
  • FORBES-TATE$80K · 2026 first_quarter
    CHMMANTRD
  • TIBER CREEK HEALTH STRATEGIES, INC.$50K · 2026 first_quarter
  • FORBES-TATE$50K · 2026 first_quarter
    AGRANIBUDMARNAT
  • TIBER CREEK GROUP$50K · 2026 first_quarter
    HCRMMMTRD
  • W STRATEGIES, LLC$50K · 2026 first_quarter
    MMM
  • BALLARD PARTNERS$80K · 2026 first_quarter
  • B HALL STRATEGIES, LLC$30K · 2026 first_quarter
    PHA

Country exposure

Domicile · not revenue geography

Approximated from company domicile — not revenue-by-geography.This panel maps the ticker to a single country using the company's registered domicile, a static lookup. It does not reflect where the company actually earns revenue or carries operational exposure (e.g. a US-domiciled chipmaker may have most of its real exposure in Taiwan or China).

🇺🇸 United States60/100
Posture: neutralView United States

Insider activity

No insider transactions filed in the last 90 days.

Federal contracts

No federal contract awards matched this company.

b5d1c9c